Fresenius Medical Care AG & Co. (NYSE:FMS) Short Interest Down 24.1% in January

Fresenius Medical Care AG & Co. (NYSE:FMS) was the recipient of a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 608,700 shares, a drop of 24.1% from the January 15th total of 802,300 shares. Based on an average trading volume of 303,600 shares, the days-to-cover ratio is presently 2.0 days. Currently, 0.1% of the company’s stock are sold short.

Shares of Fresenius Medical Care AG & Co. stock traded up $0.41 during trading on Friday, hitting $40.36. 186,000 shares of the stock traded hands, compared to its average volume of 418,784. The stock has a market cap of $24.20 billion, a P/E ratio of 17.03, a PEG ratio of 2.70 and a beta of 1.47. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.75 and a current ratio of 0.98. Fresenius Medical Care AG & Co. has a twelve month low of $31.63 and a twelve month high of $42.75. The company has a fifty day moving average price of $38.14 and a two-hundred day moving average price of $35.66.

A number of brokerages have commented on FMS. Jefferies Financial Group upgraded Fresenius Medical Care AG & Co. from a “hold” rating to a “buy” rating and set a $44.50 price objective for the company in a research report on Tuesday, January 21st. ValuEngine lowered Fresenius Medical Care AG & Co. from a “hold” rating to a “sell” rating in a research report on Tuesday, December 10th. Redburn Partners restated a “neutral” rating on shares of Fresenius Medical Care AG & Co. in a research report on Wednesday, October 23rd. DZ Bank restated a “neutral” rating on shares of Fresenius Medical Care AG & Co. in a research report on Wednesday, October 30th. Finally, Morgan Stanley lowered Fresenius Medical Care AG & Co. from an “equal weight” rating to an “underweight” rating in a report on Friday, December 6th. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $45.55.

Several institutional investors have recently made changes to their positions in FMS. NumerixS Investment Technologies Inc bought a new position in shares of Fresenius Medical Care AG & Co. in the 4th quarter valued at approximately $29,000. Whittier Trust Co. bought a new position in shares of Fresenius Medical Care AG & Co. in the 3rd quarter valued at approximately $46,000. Ladenburg Thalmann Financial Services Inc. raised its stake in shares of Fresenius Medical Care AG & Co. by 70.0% in the 2nd quarter. Ladenburg Thalmann Financial Services Inc. now owns 1,853 shares of the company’s stock valued at $73,000 after acquiring an additional 763 shares in the last quarter. Point72 Asset Management L.P. bought a new position in shares of Fresenius Medical Care AG & Co. in the 3rd quarter valued at approximately $124,000. Finally, FMR LLC raised its stake in shares of Fresenius Medical Care AG & Co. by 132.4% in the 4th quarter. FMR LLC now owns 5,372 shares of the company’s stock valued at $198,000 after acquiring an additional 3,060 shares in the last quarter. Institutional investors and hedge funds own 1.35% of the company’s stock.

About Fresenius Medical Care AG & Co.

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Featured Story: What is the Rule of 72?

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.